Redefining Drug Discovery

Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve is deploying this platform to build a pipeline of novel cancer drugs.